The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: A preliminary report

Spine

Volumn 25, Issue 3, 2000, Pages 376-381

  Boden, Scott D ^a,e   Zdeblick, Thomas A ^b   Sandhu, Harvinder S ^c   Heim, Stephen E ^d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

^d Orthopaedic Associates of DuPage   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone graft substitute; Bone morphogenetic protein; Degenerative disc disease; Human clinical trial; Interbody fusion cage; Lumbar spine arthrodesis; Osteoinduction

Indexed keywords

COLLAGEN TYPE 1; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ADULT; ARTICLE; AUTOGRAFT; BONE GRAFT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; ILIAC CREST; INTERVERTEBRAL DISK DEGENERATION; LUMBAR DISK; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPINE FUSION; SPINE RADIOGRAPHY; SPONGE; SURGICAL EQUIPMENT; TISSUE INDUCTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ARTHRODESIS; BONE MORPHOGENETIC PROTEINS; BONE TRANSPLANTATION; COLLAGEN; FEMALE; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOGENESIS; PILOT PROJECTS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; SPINAL DISEASES; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0033954803     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007632-200002010-00020     Document Type: Article

References (45)

1. Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA. Complications of iliac crest bone graft harvesting. Clin Orthop 1996;329:300-9.
2. Aspenberg P, Turek T. BMP-2 for intramuscular bone induction: Effect insquirrel monkeys is dependent on implantation site. Acta Orthop Scand 1996;67: 3-6.
3. Banwart JC, Asher MA, Hassanein RS. Iliac crest bone graft harvest donor site morbidity: A statistical evaluation. Spine 1995;20:1055-60.
4. Boden SD, Martin GJ, Horton WC, Truss TL, Sandhu HS. Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. J Spinal Disord 1998;11:95-101.
5. Boden SD, Moskovitz PA, Morone MA, Toribitake Y. Video-assisted lateral intertransverse process arthrodesis: Validation of a new minimally invasive lumbar spinal fusion technique in the rabbit and nonhuman primate (rhesus) models. Spine 1996;21:2689-97.
6. Boden SD, Schimandle JH. Biologic enhancement of spinal fusion. Spine 1995;20(Suppl):S113-23.
7. Boden SD, Schimandle JH, Hutton WC. Volvo Award Winner in Basic Sciences. The use of an osteoinductive growth factor for lumbar spinal fusion. Part II: Study of dose, carrier, and species. Spine 1995;20:2633-44.
8. Burns BH. An operation for spondylolisthesis. Lancet 1933;224:i233.
9. Calandruccio RA, Benton BF. Anterior lumbar fusion. Clin Orthop 1964; 35:63-8.
10. David SM, Murakami T, Tabor OB, et al. Lumbar spinal fusion using recombinant human bone morphogenetic protein-2 (rhBMP-2): A randomized, blinded and controlled study. Transactions of the International Society for Study of the Lumbar Spine 1995;22:14.
11. Fairbank JCT, Davies JB, Mbaot JC, O'Brien JP. The Oswestry low back pain disability questionnaire. Physiotherapy 1980;66:271-3.
12. Fernyhough JC, Schimandle JH, Weigel MC, Edwards CC, Levine AM. Chronic donor site pain complicating bone graft harvesting from the posterior iliac crest for spinal fusion. Spine 1992;17:1474-80.
13. Fischgrund JS, James SB, Chabot MC, et al. Augmentation of autograft using rhBMP-2 and different carrier media in the canine spine fusion model. J Spinal Disord 1997;10:467-72.
14. Fraser RD. Interbody, posterior, and combined lumbar fusions. Spine 1995; 20(Suppl):S167-77.
15. Goulet JA, Senunas LE, DeSilva GE, Greenfield MLVH. Autogenous iliac crest bone graft. Clin Orthop 1997;339:76-81.
16. Grevitt M, Khazim R, Webb J, Mulholland R, Shepperd J. The short form-36 health survey questionnaire in spine surgery. J Bone Joint Surg [Br] 1997;79:48-52.
17. Harmon PH. Anterior extraperitoneal lumbar disk excision and vertebral fusion. Clin Orthop 1960;18:169-98.
18. Holliger EH, Trawick RH, Boden SD, Hutton WC. Morphology of the lumbar intertransverse process fusion mass in the rabbit model: A comparison between two bone graft materials - rhBMP-2 and autograft. J Spinal Disord 1996; 9:125-8.
19. Kim SS, Denis F, Lonstein JE, Winter RB. Factors affecting fusion rate in spondylolisthesis. Spine 1990;15:977-84.
20. Kozak JA, Heilman AE, O'Brien JP. Anterior lumbar fusion operations: Technique and graft materials. Clin Orthop 1994;300:45-51.
21. Kumar A, Kozak JA, Doherty BJ, Dickson JH. Interspace distraction and graft subsidence after anterior lumbar fusion with femoral strut allograft. Spine 1993;18:2393-400.
22. Kuslich SD, Ulstrom CL, Griffith SL, Ahern JW, Dowdle JD. The Bagby and Kuslich method of lumbar interbody fusion. Spine 1998;23:1267-79.
23. Laurie SWS, Kahan LB, Mulliken JB, Murray JE. Donor-site morbidity after harvesting rib and iliac bone. Plast Reconstr Surg 1984;73:933-8.
24. Martin GJ, Boden SD, Morone MA, Moskovitz PA. Posterolateral intertransverse process spinal fusion arthrodesis with rhBMP-2 in a non-human primate: Important lessons learned regarding dose, carrier, and safety. J Spinal Disord 1999;12:179-86.
25. McHorney CA, Ware JE, Lu R, Sherbourne CD. The MOS 36-item short form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse groups. Med Care 1994;32:40-66.
26. Muschler GF, Hyodo A, Manning T, Kambic H, Easley K. Evaluation of human bone morphogenetic protein 2 in a canine spinal fusion model. Clin Orthop 1994;308:229-40.
27. Rawlinson JN. Morbidity after anterior cervical decompression and fusion: The influence of the donor site on recovery, and the results of a trial of surgibone compared to autologous bone. Acta Neurochir 1994;131:106-18.
28. Ray CD. Threaded titanium cages for lumbar interbody fusions. Spine 1997; 22:667-80.
29. Sacks S. Anterior interbody fusion of the lumbar spine: Indications and results in 200 cases. Clin Orthop 1966;44:163-70.
30. Sandhu HS, Kabo JM, Turner AS, Liu D, Kanim LEA, Toth JM. RhBMP-2 augmentation of titanium fusion cages for experimental anterior lumbar fusion. Proceedings of the 11th Annual meeting of the North Amican Spine Society. Rosemont, IL: North American Spine Society 1996:47.
31. Sandhu HS, Kanim LEA, Kabo JM, et al. Effective doses of recombinant bone morphogenetic protein-2 in experimental spinal fusion. Spine 1996;21:2115-22.
32. Sandhu HS, Kanim LEA, Kabo JM, et al. Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model. Spine 1995;20:2669-82.
33. Sandhu HS, Kanim LEA, Toth JM, et al. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements. Spine 1997;22:1171-80.
34. Schimandle JH, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 (rhBMP-2). Spine 1995;20: 1326-37.
35. Schnee CL, Freese A, Weil RJ, Marcotte PJ. Analysis of harvest morbidity and radiographic outcome using autograft for anterior cervical fusion. Spine 1997;22:2222-7.
36. Shuster JJ. CRC Handbook of Sample Size: Guidelines for Clinical Trial. Boca Raton: CRC Press, 1990.
37. Sorenson KH. Anterior interbody lumbar spine fusion for incapacitating disc degeneration and spondylolisthesis. Acta Orthop Scand 1978;49:269-77.
38. Stauffer, RN, Coventry, MB. Anterior interbody lumbar spine fusion. J Bone Joint Surg [Am] 1972;54:756-68.
39. Stewart AL, Hays RD, Ware JE. The MOS short form general health survey (SF-36). Med Care 1988;26:724-32.
40. Urist MR. Bone. Formation by autoinduction. Science 1965;150:893-9.
41. Urist MR, Strates BS. Bone morphogenetic protein. J Dent Res Suppl 1971; 50:1392-406.
42. Ware JE, Sherbourne CD. The MOS 36-item short form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473-83.
43. Wozney JM. Bone morphogenetic proteins and their gene expression. In: Noda M, ed. Cellular and Molecular Biology of Bone. Boston: Academic Press, Inc., 1993:131-67.
44. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 1989;3:192-5.
45. Zdeblick TA, Ghanayem AJ, Rapoff AJ, et al. Cervical interbody fusion cages: An animal model with and without bone morphogenetic protein. Spine 1998;23:758-66.